{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:12:12Z","timestamp":1783937532390,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Mycology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.mycmed.2020.101108","type":"journal-article","created":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T09:14:22Z","timestamp":1608887662000},"page":"101108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy of different antifungal drugs as initial treatment for patients with talaromycosis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"31","author":[{"given":"Lingyan","family":"Sheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2020.101108_bib0140","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/clinids\/10.3.640","article-title":"Infections caused by Penicillium marneffei in China and Southeast Asia: review of eighteen published cases and report of four more Chinese cases","volume":"10","author":"Deng","year":"1988","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.mycmed.2020.101108_bib0145","doi-asserted-by":"crossref","first-page":"637","DOI":"10.4269\/ajtmh.1984.33.637","article-title":"Penicilliosis marneffei in Thailand: report of five human cases","volume":"33","author":"Jayanetra","year":"1984","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.mycmed.2020.101108_bib0150","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0140-6736(94)91287-4","article-title":"Disseminated Penicillium marneffei infection in southeast Asia","volume":"344","author":"Supparatpinyo","year":"1994","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.mycmed.2020.101108_bib0155","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s10156-012-0511-7","article-title":"In vitro antifungal drug susceptibilities of Penicillium marneffei from China","volume":"19","author":"Liu","year":"2013","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.mycmed.2020.101108_bib0160","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4269\/ajtmh.2007.77.350","article-title":"Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients","volume":"77","author":"Supparatpinyo","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.mycmed.2020.101108_bib0165","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1086\/520280","article-title":"Amphotericin B and itraconazole for treatment of disseminated Penicillium marneffei infection in human immunodeficiency virus-infected patients","volume":"26","author":"Sirisanthana","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2020.101108_bib0170","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/BF00209535","article-title":"In vitro susceptibility of mycelial and yeast forms of Penicillium marneffei to amphotericin B, fluconazole, 5-fluorocytosine and itraconazole","volume":"9","author":"Sekhon","year":"1993","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.mycmed.2020.101108_bib0175","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1128\/AAC.37.11.2407","article-title":"Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens","volume":"37","author":"Supparatpinyo","year":"1993","journal-title":"Antimicrob Agents Chem"},{"key":"10.1016\/j.mycmed.2020.101108_bib0180","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/cid\/ciu094","volume":"58","author":"Masur","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2020.101108_bib0185","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1056\/NEJMoa1613306","article-title":"A trial of itraconazole or amphotericin B for HIV-associated talaromycosis","volume":"376","author":"Le","year":"2017","journal-title":"The N Engl J Med"},{"key":"10.1016\/j.mycmed.2020.101108_bib0190","first-page":"441","article-title":"Single use of itraconazole has no effect on treatment for Penicillium marneffei with HIV infection","volume":"18","author":"Su","year":"2015","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.mycmed.2020.101108_bib0195","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11046-012-9577-0","article-title":"Penicillium marneffei infection: an emerging disease in mainland China","volume":"175","author":"Hu","year":"2013","journal-title":"Mycopathologia"},{"key":"10.1016\/j.mycmed.2020.101108_bib0200","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1053\/jinf.2002.1062","article-title":"Disseminated Penicillium marneffei infection among HIV-infected patients in Manipur state","volume":"45","author":"Ranjana","year":"2002","journal-title":"India. J Infect"},{"key":"10.1016\/j.mycmed.2020.101108_bib0205","first-page":"495","article-title":"Penicilliosis and AIDS in Haiphong","volume":"44","author":"Son","year":"2014","journal-title":"Vietnam: evolution and predictive factors of death. Med Mal Infect"},{"key":"10.1016\/j.mycmed.2020.101108_bib0210","doi-asserted-by":"crossref","first-page":"e0195569","DOI":"10.1371\/journal.pone.0195569","article-title":"Accuracy of rapid diagnosis of Talaromyces marneffei: a systematic review and meta-analysis","volume":"13","author":"Ning","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.mycmed.2020.101108_bib0215","first-page":"103","article-title":"Clinical presentations and outcomes of Penicillium marneffei infections: a series from 1994 to 2004","volume":"14","author":"Wu","year":"2008","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.mycmed.2020.101108_bib0220","article-title":"A clinical study on 101 AIDS cases complicated with Penicilliosis Marneffei","volume":"14","author":"Li","year":"2008","journal-title":"Chin J Aids Std"},{"key":"10.1016\/j.mycmed.2020.101108_bib0225","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.revmed.2010.07.019","article-title":"Penicilliosis in Vietnam: a series of 94 patients","volume":"31","author":"Vu Hai","year":"2010","journal-title":"Rev Med Int"},{"key":"10.1016\/j.mycmed.2020.101108_bib0230","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1742-6405-9-24","article-title":"Clinical characteristics and outcome of Penicillium marneffei infection among HIV-infected patients in northern Vietnam","volume":"9","author":"Larsson","year":"2012","journal-title":"AIDS research and therapy"},{"key":"10.1016\/j.mycmed.2020.101108_bib0235","series-title":"Clinical analysis of Penicillium marneffei infection in 160 patients with varied immune states","author":"Ye","year":"2016"},{"key":"10.1016\/j.mycmed.2020.101108_bib0240","first-page":"17","article-title":"Analysis of epidemiology, clinical characteristics, treatment and outcome of 187 cases of AIDS complicated with Penicilliosis Marneffei","volume":"8","author":"Chen","year":"2018","journal-title":"Chin Med Pharm"},{"key":"10.1016\/j.mycmed.2020.101108_bib0245","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1097\/CM9.0000000000000345","article-title":"Determinants of prognosis in Talaromyces marneffei infections with respiratory system lesions","volume":"132","author":"Qiu","year":"2019","journal-title":"Chin Med J"},{"key":"10.1016\/j.mycmed.2020.101108_bib0250","series-title":"of Health Vietnam. Guidelines for hiv\/aids diagnosis and treatment","author":"Minister","year":"2009"},{"key":"10.1016\/j.mycmed.2020.101108_bib0255","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1023\/A:1007245226495","article-title":"Penicillium marneffei: types and drug susceptibility","volume":"149","author":"Imwidthaya","year":"2001","journal-title":"Mycopathologia"},{"key":"10.1016\/j.mycmed.2020.101108_bib0260","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s10096-018-3222-x","article-title":"Susceptibility profile of echinocandins, azoles and amphotericin B against yeast phase of Talaromyces marneffei isolated from HIV-infected patients in Guangdong, China","volume":"37","author":"Lei","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.mycmed.2020.101108_bib0265","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11046-019-00325-y","article-title":"In vitro susceptibility of berberine combined with antifungal agents against the yeast form of Talaromyces marneffei","volume":"184","author":"Luo","year":"2019","journal-title":"Mycopathologia"},{"key":"10.1016\/j.mycmed.2020.101108_bib0270","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/jac\/dkn494","article-title":"In vitro interactions of micafungin with amphotericin B, itraconazole or fluconazole against the pathogenic phase of Penicillium marneffei","volume":"63","author":"Cao","year":"2009","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523320302493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523320302493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:20:50Z","timestamp":1761110450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523320302493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1156523320302493"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2020.101108","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of different antifungal drugs as initial treatment for patients with talaromycosis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Medical Mycology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2020.101108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101108"}}